{"id":"8467","presentation":"A5074 - Improvements in Lung Function with Budesonide\/Glycopyrrolate\/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial","session":"C40 - PREDICTING OUTCOMES AND NEW THERAPIES IN CHRONIC OBSTRUCTIVE LUNG DISEASE","filename":"Rabe_ATS2020_P1069.pdf","speaker":"K. Rabe","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ats2020_eposter\/8467\/jpg\/rabe_ats2020_p1069\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6576\/session_token\/01ce669663b2ceda2189a32d19299cab","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]